Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

INTRODUCTION: Maintaining fluid intake sufficient to reduce arginine vasopressin (AVP) secretion has been hypothesised to slow kidney cyst growth in autosomal dominant polycystic kidney disease (ADPKD). However, evidence to support this as a clinical practice recommendation is of poor quality. The a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Wong, Annette T Y, Mannix, Carly, Grantham, Jared J, Allman-Farinelli, Margaret, Badve, Sunil V, Boudville, Neil, Byth, Karen, Chan, Jessie, Coulshed, Susan, Edwards, Marie E, Erickson, Bradley J, Fernando, Mangalee, Foster, Sheryl, Haloob, Imad, Harris, David C H, Hawley, Carmel M, Hill, Julie, Howard, Kirsten, Howell, Martin, Jiang, Simon H, Johnson, David W, Kline, Timothy L, Kumar, Karthik, Lee, Vincent W, Lonergan, Maureen, Mai, Jun, McCloud, Philip, Peduto, Anthony, Rangan, Anna, Roger, Simon D, Sud, Kamal, Torres, Vincent, Vliayuri, Eswari, Rangan, Gopala K
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Renal Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5780847/
https://ncbi.nlm.nih.gov/pubmed/29358433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-018794
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars